Peter Dixon
Impact in
- Oncology top 1%
- Drug Transport and Resistance Mechanisms
- Lung Cancer Research Studies
- Hepatology top 2%
Papers in
- Co-authors
- Catherine Williamson (38 shared papers)Michael Brundage (11 shared papers)Nicholas Wood (7 shared papers)Joseph L. Pater (3 shared papers)Jenny Chambers (15 shared papers)Enza Maria Valente (5 shared papers)W.J. Mackillop (6 shared papers)William K. Evans (3 shared papers)
- Journals
- International Journal of Radiation Oncology*Biology*Physics (9 papers)Journal of Bone and Mineral Research (5 papers)Journal of Medical Genetics (4 papers)Journal of Clinical Oncology (4 papers)Journal of Hepatology (4 papers)
- Partner nations
- United KingdomCanadaUnited States
In The Last Decade
Peter Dixon
111 papers receiving 5.0k citations
Peter Dixon's Hit Papers
Peers
Comparison fields: 5 of 131
- Oncology 2.0k
- Hepatology 300
- Neurology 439
- Nephrology 187
- Obstetrics and Gynecology 167
Countries citing papers authored by Peter Dixon
This map shows the geographic impact of Peter Dixon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Dixon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Dixon more than expected).
Fields of papers citing papers by Peter Dixon
This network shows the impact of papers produced by Peter Dixon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Dixon. The network helps show where Peter Dixon may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Dixon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 113 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer. The National Cancer Institute of Canada Clinical Trials Group. Hit paper breakdown → | 1993 | 515 |
| 2 | 2001 | 352 | |
| 3 | 2000 | 202 | |
| 4 | 2007 | 189 | |
| 5 | 2016 | 147 | |
| 6 | 2008 | 144 | |
| 7 | 1997 | 138 | |
| 8 | 2016 | 127 | |
| 9 | 1994 | 126 | |
| 10 | 2002 | 117 | |
| 11 | 2009 | 114 | |
| 12 | 2014 | 105 | |
| 13 | 1997 | 104 | |
| 14 | 2011 | 102 | |
| 15 | 1998 | 98 | |
| 16 | 2017 | 97 | |
| 17 | 2011 | 94 | |
| 18 | 2018 | 94 | |
| 19 | 1999 | 93 | |
| 20 | 2013 | 91 |
About Peter Dixon
Peter Dixon is a scholar working on Oncology, Surgery, Molecular Biology, Radiology, Nuclear Medicine and Imaging and Pulmonary and Respiratory Medicine, having authored 113 papers that have together received 5.2k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (33 papers), Pediatric Hepatobiliary Diseases and Treatments (19 papers), Advances in Oncology and Radiotherapy (10 papers), Aquaculture disease management and microbiota (10 papers), Liver Disease Diagnosis and Treatment (7 papers), Pregnancy and Medication Impact (7 papers), Advanced Radiotherapy Techniques (6 papers) and Lung Cancer Diagnosis and Treatment (6 papers). The work is most often cited by research in Oncology (2.0k citations), Hepatology (300 citations), Neurology (439 citations), Nephrology (187 citations) and Obstetrics and Gynecology (167 citations). Peter Dixon has collaborated with scholars based in United Kingdom, Canada and United States. Frequent co-authors include Catherine Williamson, Michael Brundage, Nicholas Wood, Joseph L. Pater, Jenny Chambers, Enza Maria Valente, W.J. Mackillop, William K. Evans, Benny Zee and Nevin Murray. Their work appears in journals such as International Journal of Radiation Oncology*Biology*Physics, Journal of Bone and Mineral Research, Journal of Medical Genetics, Journal of Clinical Oncology and Journal of Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.